DDX54 downregulation enhances anti-PD1 therapy in immune-desert lung tumors with high tumor mutational burden. Gong JR, Lee J, Han Y, Cho KH, et al. Proc Natl Acad Sci U S A 2025;122:e2412310122.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gong JR, Lee J, Han Y, Cho KH, et al. DDX54 downregulation enhances anti-PD1 therapy in immune-desert lung tumors with high tumor mutational burden. Proc Natl Acad Sci U S A 2025;122:e2412310122.
PMID: 40172969